Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 578 of 1,261
  1. US 9913822

    Combination therapy with an anti-hyaluronan agent and therapeutic agent

    HALOZYME, INC. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  2. US 9913820

    Antimicrobial compositions comprising glyceryl nitrates

    The Board of Regents of the University of Texas System · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  3. US 9914722

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  4. US 9908879

    P2X3 and/or P2X2/3 compounds and methods

    Asana BioSciences, LLC · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  5. US 9909124

    Compounds and methods for modulating apolipoprotein C-III expression for improving a diabetic profile

    Ionis Pharmaceuticals, Inc. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  6. US 9910031

    Compositions and methods for modulating c-Rel-dependent cytokine production

    Madrigal Pharmaceuticals, Inc. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  7. US 9908856

    Therapeutic compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  8. US 9907834

    Use of C-type natriuretic peptide variants to treat skeletal dysplasia

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  9. US 9907856

    Carboxymethylcellulose-peptide conjugates and methods for using the same

    The Regents of the University of California · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  10. US 9907855

    N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides

    Nektar Therapeutics · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  11. US 9907796

    Methods of treating tumoral diseases, or bacterial or viral infections

    Inhibikase Therapeutics, Inc. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  12. US 9907789

    Sustained-release preparation

    Takeda Pharmaceutical Company Limited · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  13. US 9909188

    Methods and compositions involving lincRNA and leukemia

    The Regents of the University of California · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  14. US 9907803

    Methods for treating attention deficit hyperactivity disorder

    REVIVA PHARMACEUTICALS, INC. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  15. US 9907788

    Inhibition of crystal growth of roflumilast

    Arcutis, Inc. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  16. US 9908916

    Peptide for suppressing osteoclast differentiation and use thereof

    CAREGEN CO., LTD. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  17. US 9907747

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  18. US 9907479

    Contribution of oxidative stress to AF electrograms

    Northwestern University · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  19. US 9908970

    Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

    Nektar Therapeutics · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  20. US 9907762

    Stabilized mutant opsin proteins

    Regents of the University of Minnesota · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  21. US 9907807

    Topical pharmaceutical compositions

    Almirall, S.A. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  22. US 9908899

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  23. US 9907820

    Polyclonal gamma delta T cells for immunotherapy

    The Board of Regents of the University of Texas System · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted
  24. US 9908841

    Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.